TrialCancer medicine2021

A randomized, double-blind, phase II study of oral histone deacetylase inhibitor resminostat plus S-1 versus placebo plus S-1 in biliary tract cancers previously treated with gemcitabine plus platinum-based chemotherapy.

Makoto Ueno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.